References
1. Finglas PM. Thiamine. Int J Vitam Nutr Res 1993;63:270–274.
2. Seligmann R, Levi R, Konijn AM, et al. Thiamine deficiency in patients with B-chronic lymphocytic leukaemia: a pilot study. Postgrad Med J 2001;77:582–585.
3. Kalmanchey R, Roos R, Majtenyi K, et al. Wernicke-encephalopathy in children with cancer. Med Pedriatr Oncol 1994;22:133–136.
4. Comin-Anduix B, Boren J, Martinez S, et al. The effect of thiamine supplementation on tumour proliferation: a metabolic control analysis study. Eur J Biochem 2001;268:4177–4182.
5. Basu TK, Dickerson JW. The thiamine status of early cancer patients with particular reference to those with breast and bronchial carcinomas. Oncology 1976;33:250–252.
6. Victor M, Adams RA, Collins GH. The Wernicke-Korsakoff syndrome and related disorders due to alcoholism and malnutrition. Philadelphia, FA Davis, 1989.
7. Harper CG, Giles M, Finlay-Jones R. Clinical signs in the Wernicke-Korsakoff complex: a retrospective analysis of 131 cases diagnosed at necropsy. J Neurol Neurosurg Psychiatry 1986;49:341–345.
8. Caine D, Halliday GM, Kril JJ, et al. Operational criteria for the classification of chronic alcoholics: identification of Wernicke's encephalopathy. J Neurol Neurosurg Psychiatry 1997;62:51–60.
9. Leigh D, McBurney A, McIlwain H. Erythrocyte transketolase activity in the Wernicke-Korsakoff syndrome. Br J Psychiatry 1981;139:153–156.
10. O' Keefe ST. Thiamine deficiency in elderly people. Age Ageing 2000;29:99–101.
11. Warach SJ, Charness ME. Imaging the brain lesions of alcoholics. In Greenberg JO (ed). Neuroimaging: A companion to Adams and Victor's principles of neurology. New York, McGraw-Hill 1994;503.
12. McDowell JR, Le Blanc HJ. Computed tomographic findings in Wernicke-Korsakoff syndrome. Arch Neurol 1984;41:453–454.
13. Mensing JW, Hoogland PH, Slooff JL. Computed tomography in the diagnosis of Wernicke's encephalopathy: a radiological-neuropathological correlation. Ann Neurol 1984;16:363–365.
14. Antunez E, Estruch R, Cardenal C, et al. Usefulness of CT and MR imaging in the diagnosis of acute Wernicke's encephalopathy. AJR Am J Roentgenol 1998;171:1131–1137.
15. Charness ME. Intracranial voyeurism: revealing the mammillary bodies in alcoholism. Alcohol Clin Exp Res 1999;23:1941–1944.
16. Charness ME, DeLaPaz RL. Periodic alternating nystagmus in an alcoholic with small mammillary bodies. Neurology 1988;38(Suppl):421.
17. Charness ME, DeLaPaz RL. Mammillary body atrophy in Wernicke's encphalpathy: antemortem identification using magnetic resonance imaging. Ann Neurol 1987;22:595–600.
18. Park SH, Kim M, Na DL, et al. Magnetic resonance reflects the pathological evolution of Wernicke encephalopathy. J Neuroimaging 2001;11:406–410.
19. Koguchi K, Nakatsuji Y, Abe K, et al. Wernicke's encephalopathy after glucose infusion. Neurology 2004;62:512.
20. Langlais PJ, Mair RG. Protective effects of the glutamate antagonis MK-801 on pyrithiamine-induced lesions and amino acid changes in rat brain. J Neurosci 1990;10:1664–1674.
21. Martin PR, Singleton CK, Hiller-Sturmhofel S. The role of thiamine deficiency in alcoholic brain disease. Alcohol Res Health 2003;27:134–142.
22. Thomson AD, Ryle PR, Shaw GK. Ethanol, thiamine, and brain damage. Alcohol Alcohol 1983;18:27.
23. Agabio R. Thiamine administration in alcohol-dependent patients. Alcohol Alcohol 2005;40:155–156.
24. Thomson AD, Cook CC, Touquet R, et al. The Royal College of Physicians report on alcohol: guidelines for managing Wernicke's encephalopathy in the accident and Emergency Department. Alcohol Alcohol 2002;37:513–521.
25. Day E, Bentham P, Callaghan R, et al. Thiamine for Wernicke-Korsakoff syndrome in people at risk from alcohol abuse. Cochrane Database Syst Rev 2004;CD004033.
26. Ambrose ML, Bowden SC, Whelan G. Thiamine treatment and working memory function of alcohol-dependent people: preliminary findings. Alcohol Clin Exp Res 2001;25:112–116.